Global Hadron Therapy Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Radiation therapy is the medical use of ionizing radiation to treat cancer. In conventional radiation therapy, beams of X rays (high energy photons) are produced by accelerated electrons and then delivered to the patient to destroy tumour cells. Using crossing beams from many angles, radiation oncologists irradiate the tumour target while trying to spare the surrounding normal tissues. Inevitably some radiation dose is always deposited in the healthy tissues.
Scope of the Report:
When the irradiating beams are made of charged particles (protons and other ions, such as carbon), radiation therapy is called hadrontherapy. The strength of hadrontherapy lies in the unique physical and radiobiological properties of these particles; they can penetrate the tissues with little diffusion and deposit the maximum energy just before stopping. This allows a precise definition of the specific region to be irradiated. The peaked shape of the hadron energy deposition is called Bragg peak and has become the symbol of hadrontherapy. With the use of hadrons the tumour can be irradiated while the damage to healthy tissues is less than with X-rays.
The idea of using protons for cancer treatment was first proposed in 1946 by the physicist Robert Wilson, who later became the founder and first director of the Fermi National Accelerator Laboratory (Fermilab) near Chicago. The first patients were treated in the 1950s in nuclear physics research facilities by means of non-dedicated accelerators. Initially, the clinical applications were limited to few parts of the body, as accelerators were not powerful enough to allow protons to penetrate deep in the tissues.
In the late 1970s improvements in accelerator technology, coupled with advances in medical imaging and computing, made proton therapy a viable option for routine medical applications. However, it has only been since the beginning of the 1990s that proton facilities have been established in clinical settings, the first one being in Loma Linda, USA. Currrently about thirty proton centres are either in operation or in construction worldwide.
The worldwide market for Hadron Therapy is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Hadron Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Hadron Therapy Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Hadron Therapy, with sales, revenue, and price of Hadron Therapy, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show The global market by regions, with sales, revenue and market share of Hadron Therapy, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Hadron Therapy market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Hadron Therapy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Scope of the Report:
When the irradiating beams are made of charged particles (protons and other ions, such as carbon), radiation therapy is called hadrontherapy. The strength of hadrontherapy lies in the unique physical and radiobiological properties of these particles; they can penetrate the tissues with little diffusion and deposit the maximum energy just before stopping. This allows a precise definition of the specific region to be irradiated. The peaked shape of the hadron energy deposition is called Bragg peak and has become the symbol of hadrontherapy. With the use of hadrons the tumour can be irradiated while the damage to healthy tissues is less than with X-rays.
The idea of using protons for cancer treatment was first proposed in 1946 by the physicist Robert Wilson, who later became the founder and first director of the Fermi National Accelerator Laboratory (Fermilab) near Chicago. The first patients were treated in the 1950s in nuclear physics research facilities by means of non-dedicated accelerators. Initially, the clinical applications were limited to few parts of the body, as accelerators were not powerful enough to allow protons to penetrate deep in the tissues.
In the late 1970s improvements in accelerator technology, coupled with advances in medical imaging and computing, made proton therapy a viable option for routine medical applications. However, it has only been since the beginning of the 1990s that proton facilities have been established in clinical settings, the first one being in Loma Linda, USA. Currrently about thirty proton centres are either in operation or in construction worldwide.
The worldwide market for Hadron Therapy is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Hadron Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Koninklijke Philips N.V.
- Advanced Oncotherapy
- Varian Medical Systems, Inc.
- Optivus Proton Therapy, Inc.
- Hitachi, Ltd.
- Mevion Medical Systems
- ProTom International
- Mitsubishi Electric Corporation
- Sumitomo Corporation
- ProNova Solutions, LLC
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Electron Beam
- Proton Beam
- Neutron Beam
- Carbon Ion Beam
- Alpha Particle Beam
- Beta Particle Beam
- Pediatric Cancer
- Bone and Soft Tissue Cancer
- Prostate Cancer
- Lung Cancer
- Liver Cancer
- Eye Cancer
- Head & Neck Cancer
- Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
Chapter 1, to describe Hadron Therapy Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Hadron Therapy, with sales, revenue, and price of Hadron Therapy, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show The global market by regions, with sales, revenue and market share of Hadron Therapy, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Hadron Therapy market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Hadron Therapy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 Hadron Therapy Introduction
1.2 Market Analysis by Type
1.2.1 Electron Beam
1.2.2 Proton Beam
1.2.3 Neutron Beam
1.2.4 Carbon Ion Beam
1.2.5 Alpha Particle Beam
1.2.6 Beta Particle Beam
1.3 Market Analysis by Applications
1.3.1 Pediatric Cancer
1.3.2 Bone and Soft Tissue Cancer
1.3.3 Prostate Cancer
1.3.4 Lung Cancer
1.3.5 Liver Cancer
1.3.6 Eye Cancer
1.3.7 Head & Neck Cancer
1.3.8 Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Koninklijke Philips N.V.
2.1.1 Business Overview
2.1.2 Hadron Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Koninklijke Philips N.V. Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Advanced Oncotherapy
2.2.1 Business Overview
2.2.2 Hadron Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Advanced Oncotherapy Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Varian Medical Systems, Inc.
2.3.1 Business Overview
2.3.2 Hadron Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Varian Medical Systems, Inc. Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Optivus Proton Therapy, Inc.
2.4.1 Business Overview
2.4.2 Hadron Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Optivus Proton Therapy, Inc. Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Hitachi, Ltd.
2.5.1 Business Overview
2.5.2 Hadron Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Hitachi, Ltd. Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Mevion Medical Systems
2.6.1 Business Overview
2.6.2 Hadron Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Mevion Medical Systems Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 ProTom International
2.7.1 Business Overview
2.7.2 Hadron Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 ProTom International Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Mitsubishi Electric Corporation
2.8.1 Business Overview
2.8.2 Hadron Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Mitsubishi Electric Corporation Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sumitomo Corporation
2.9.1 Business Overview
2.9.2 Hadron Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sumitomo Corporation Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 ProNova Solutions, LLC
2.10.1 Business Overview
2.10.2 Hadron Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 ProNova Solutions, LLC Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL HADRON THERAPY SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)
3.1 Global Hadron Therapy Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Hadron Therapy Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Hadron Therapy Manufacturer Market Share in 2017
3.3.2 Top 6 Hadron Therapy Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 GLOBAL HADRON THERAPY MARKET ANALYSIS BY REGIONS
4.1 Global Hadron Therapy Sales, Revenue and Market Share by Regions
4.1.1 Global Hadron Therapy Sales and Market Share by Regions (2013-2018)
4.1.2 Global Hadron Therapy Revenue and Market Share by Regions (2013-2018)
4.2 North America Hadron Therapy Sales and Growth Rate (2013-2018)
4.3 Europe Hadron Therapy Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Hadron Therapy Sales and Growth Rate (2013-2018)
4.5 South America Hadron Therapy Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Hadron Therapy Sales and Growth Rate (2013-2018)
5 NORTH AMERICA HADRON THERAPY BY COUNTRIES
5.1 North America Hadron Therapy Sales, Revenue and Market Share by Countries
5.1.1 North America Hadron Therapy Sales and Market Share by Countries (2013-2018)
5.1.2 North America Hadron Therapy Revenue and Market Share by Countries (2013-2018)
5.2 United States Hadron Therapy Sales and Growth Rate (2013-2018)
5.3 Canada Hadron Therapy Sales and Growth Rate (2013-2018)
5.4 Mexico Hadron Therapy Sales and Growth Rate (2013-2018)
6 EUROPE HADRON THERAPY BY COUNTRIES
6.1 Europe Hadron Therapy Sales, Revenue and Market Share by Countries
6.1.1 Europe Hadron Therapy Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Hadron Therapy Revenue and Market Share by Countries (2013-2018)
6.2 Germany Hadron Therapy Sales and Growth Rate (2013-2018)
6.3 UK Hadron Therapy Sales and Growth Rate (2013-2018)
6.4 France Hadron Therapy Sales and Growth Rate (2013-2018)
6.5 Russia Hadron Therapy Sales and Growth Rate (2013-2018)
6.6 Italy Hadron Therapy Sales and Growth Rate (2013-2018)
7 ASIA-PACIFIC HADRON THERAPY BY COUNTRIES
7.1 Asia-Pacific Hadron Therapy Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Hadron Therapy Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Hadron Therapy Revenue and Market Share by Countries (2013-2018)
7.2 China Hadron Therapy Sales and Growth Rate (2013-2018)
7.3 Japan Hadron Therapy Sales and Growth Rate (2013-2018)
7.4 Korea Hadron Therapy Sales and Growth Rate (2013-2018)
7.5 India Hadron Therapy Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Hadron Therapy Sales and Growth Rate (2013-2018)
8 SOUTH AMERICA HADRON THERAPY BY COUNTRIES
8.1 South America Hadron Therapy Sales, Revenue and Market Share by Countries
8.1.1 South America Hadron Therapy Sales and Market Share by Countries (2013-2018)
8.1.2 South America Hadron Therapy Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Hadron Therapy Sales and Growth Rate (2013-2018)
8.3 Argentina Hadron Therapy Sales and Growth Rate (2013-2018)
8.4 Colombia Hadron Therapy Sales and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA HADRON THERAPY BY COUNTRIES
9.1 Middle East and Africa Hadron Therapy Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Hadron Therapy Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Hadron Therapy Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Hadron Therapy Sales and Growth Rate (2013-2018)
9.3 UAE Hadron Therapy Sales and Growth Rate (2013-2018)
9.4 Egypt Hadron Therapy Sales and Growth Rate (2013-2018)
9.5 Nigeria Hadron Therapy Sales and Growth Rate (2013-2018)
9.6 South Africa Hadron Therapy Sales and Growth Rate (2013-2018)
10 GLOBAL HADRON THERAPY MARKET SEGMENT BY TYPE
10.1 Global Hadron Therapy Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Hadron Therapy Sales and Market Share by Type (2013-2018)
10.1.2 Global Hadron Therapy Revenue and Market Share by Type (2013-2018)
10.2 Electron Beam Sales Growth and Price
10.2.1 Global Electron Beam Sales Growth (2013-2018)
10.2.2 Global Electron Beam Price (2013-2018)
10.3 Proton Beam Sales Growth and Price
10.3.1 Global Proton Beam Sales Growth (2013-2018)
10.3.2 Global Proton Beam Price (2013-2018)
10.4 Neutron Beam Sales Growth and Price
10.4.1 Global Neutron Beam Sales Growth (2013-2018)
10.4.2 Global Neutron Beam Price (2013-2018)
10.5 Carbon Ion Beam Sales Growth and Price
10.5.1 Global Carbon Ion Beam Sales Growth (2013-2018)
10.5.2 Global Carbon Ion Beam Price (2013-2018)
10.6 Alpha Particle Beam Sales Growth and Price
10.6.1 Global Alpha Particle Beam Sales Growth (2013-2018)
10.6.2 Global Alpha Particle Beam Price (2013-2018)
10.7 Beta Particle Beam Sales Growth and Price
10.7.1 Global Beta Particle Beam Sales Growth (2013-2018)
10.7.2 Global Beta Particle Beam Price (2013-2018)
11 GLOBAL HADRON THERAPY MARKET SEGMENT BY APPLICATION
11.1 Global Hadron Therapy Sales Market Share by Application (2013-2018)
11.2 Pediatric Cancer Sales Growth (2013-2018)
11.3 Bone and Soft Tissue Cancer Sales Growth (2013-2018)
11.4 Prostate Cancer Sales Growth (2013-2018)
11.5 Lung Cancer Sales Growth (2013-2018)
11.6 Liver Cancer Sales Growth (2013-2018)
11.7 Eye Cancer Sales Growth (2013-2018)
11.8 Head & Neck Cancer Sales Growth (2013-2018)
11.9 Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma) Sales Growth (2013-2018)
12 HADRON THERAPY MARKET FORECAST (2018-2023)
12.1 Global Hadron Therapy Sales, Revenue and Growth Rate (2018-2023)
12.2 Hadron Therapy Market Forecast by Regions (2018-2023)
12.2.1 North America Hadron Therapy Market Forecast (2018-2023)
12.2.2 Europe Hadron Therapy Market Forecast (2018-2023)
12.2.3 Asia-Pacific Hadron Therapy Market Forecast (2018-2023)
12.2.4 South America Hadron Therapy Market Forecast (2018-2023)
12.2.5 Middle East and Africa Hadron Therapy Market Forecast (2018-2023)
12.3 Hadron Therapy Market Forecast by Type (2018-2023)
12.3.1 Global Hadron Therapy Sales Forecast by Type (2018-2023)
12.3.2 Global Hadron Therapy Market Share Forecast by Type (2018-2023)
12.4 Hadron Therapy Market Forecast by Application (2018-2023)
12.4.1 Global Hadron Therapy Sales Forecast by Application (2018-2023)
12.4.2 Global Hadron Therapy Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 Hadron Therapy Introduction
1.2 Market Analysis by Type
1.2.1 Electron Beam
1.2.2 Proton Beam
1.2.3 Neutron Beam
1.2.4 Carbon Ion Beam
1.2.5 Alpha Particle Beam
1.2.6 Beta Particle Beam
1.3 Market Analysis by Applications
1.3.1 Pediatric Cancer
1.3.2 Bone and Soft Tissue Cancer
1.3.3 Prostate Cancer
1.3.4 Lung Cancer
1.3.5 Liver Cancer
1.3.6 Eye Cancer
1.3.7 Head & Neck Cancer
1.3.8 Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Koninklijke Philips N.V.
2.1.1 Business Overview
2.1.2 Hadron Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Koninklijke Philips N.V. Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Advanced Oncotherapy
2.2.1 Business Overview
2.2.2 Hadron Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Advanced Oncotherapy Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Varian Medical Systems, Inc.
2.3.1 Business Overview
2.3.2 Hadron Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Varian Medical Systems, Inc. Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Optivus Proton Therapy, Inc.
2.4.1 Business Overview
2.4.2 Hadron Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Optivus Proton Therapy, Inc. Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Hitachi, Ltd.
2.5.1 Business Overview
2.5.2 Hadron Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Hitachi, Ltd. Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Mevion Medical Systems
2.6.1 Business Overview
2.6.2 Hadron Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Mevion Medical Systems Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 ProTom International
2.7.1 Business Overview
2.7.2 Hadron Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 ProTom International Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Mitsubishi Electric Corporation
2.8.1 Business Overview
2.8.2 Hadron Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Mitsubishi Electric Corporation Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sumitomo Corporation
2.9.1 Business Overview
2.9.2 Hadron Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sumitomo Corporation Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 ProNova Solutions, LLC
2.10.1 Business Overview
2.10.2 Hadron Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 ProNova Solutions, LLC Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL HADRON THERAPY SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)
3.1 Global Hadron Therapy Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Hadron Therapy Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Hadron Therapy Manufacturer Market Share in 2017
3.3.2 Top 6 Hadron Therapy Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 GLOBAL HADRON THERAPY MARKET ANALYSIS BY REGIONS
4.1 Global Hadron Therapy Sales, Revenue and Market Share by Regions
4.1.1 Global Hadron Therapy Sales and Market Share by Regions (2013-2018)
4.1.2 Global Hadron Therapy Revenue and Market Share by Regions (2013-2018)
4.2 North America Hadron Therapy Sales and Growth Rate (2013-2018)
4.3 Europe Hadron Therapy Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Hadron Therapy Sales and Growth Rate (2013-2018)
4.5 South America Hadron Therapy Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Hadron Therapy Sales and Growth Rate (2013-2018)
5 NORTH AMERICA HADRON THERAPY BY COUNTRIES
5.1 North America Hadron Therapy Sales, Revenue and Market Share by Countries
5.1.1 North America Hadron Therapy Sales and Market Share by Countries (2013-2018)
5.1.2 North America Hadron Therapy Revenue and Market Share by Countries (2013-2018)
5.2 United States Hadron Therapy Sales and Growth Rate (2013-2018)
5.3 Canada Hadron Therapy Sales and Growth Rate (2013-2018)
5.4 Mexico Hadron Therapy Sales and Growth Rate (2013-2018)
6 EUROPE HADRON THERAPY BY COUNTRIES
6.1 Europe Hadron Therapy Sales, Revenue and Market Share by Countries
6.1.1 Europe Hadron Therapy Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Hadron Therapy Revenue and Market Share by Countries (2013-2018)
6.2 Germany Hadron Therapy Sales and Growth Rate (2013-2018)
6.3 UK Hadron Therapy Sales and Growth Rate (2013-2018)
6.4 France Hadron Therapy Sales and Growth Rate (2013-2018)
6.5 Russia Hadron Therapy Sales and Growth Rate (2013-2018)
6.6 Italy Hadron Therapy Sales and Growth Rate (2013-2018)
7 ASIA-PACIFIC HADRON THERAPY BY COUNTRIES
7.1 Asia-Pacific Hadron Therapy Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Hadron Therapy Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Hadron Therapy Revenue and Market Share by Countries (2013-2018)
7.2 China Hadron Therapy Sales and Growth Rate (2013-2018)
7.3 Japan Hadron Therapy Sales and Growth Rate (2013-2018)
7.4 Korea Hadron Therapy Sales and Growth Rate (2013-2018)
7.5 India Hadron Therapy Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Hadron Therapy Sales and Growth Rate (2013-2018)
8 SOUTH AMERICA HADRON THERAPY BY COUNTRIES
8.1 South America Hadron Therapy Sales, Revenue and Market Share by Countries
8.1.1 South America Hadron Therapy Sales and Market Share by Countries (2013-2018)
8.1.2 South America Hadron Therapy Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Hadron Therapy Sales and Growth Rate (2013-2018)
8.3 Argentina Hadron Therapy Sales and Growth Rate (2013-2018)
8.4 Colombia Hadron Therapy Sales and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA HADRON THERAPY BY COUNTRIES
9.1 Middle East and Africa Hadron Therapy Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Hadron Therapy Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Hadron Therapy Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Hadron Therapy Sales and Growth Rate (2013-2018)
9.3 UAE Hadron Therapy Sales and Growth Rate (2013-2018)
9.4 Egypt Hadron Therapy Sales and Growth Rate (2013-2018)
9.5 Nigeria Hadron Therapy Sales and Growth Rate (2013-2018)
9.6 South Africa Hadron Therapy Sales and Growth Rate (2013-2018)
10 GLOBAL HADRON THERAPY MARKET SEGMENT BY TYPE
10.1 Global Hadron Therapy Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Hadron Therapy Sales and Market Share by Type (2013-2018)
10.1.2 Global Hadron Therapy Revenue and Market Share by Type (2013-2018)
10.2 Electron Beam Sales Growth and Price
10.2.1 Global Electron Beam Sales Growth (2013-2018)
10.2.2 Global Electron Beam Price (2013-2018)
10.3 Proton Beam Sales Growth and Price
10.3.1 Global Proton Beam Sales Growth (2013-2018)
10.3.2 Global Proton Beam Price (2013-2018)
10.4 Neutron Beam Sales Growth and Price
10.4.1 Global Neutron Beam Sales Growth (2013-2018)
10.4.2 Global Neutron Beam Price (2013-2018)
10.5 Carbon Ion Beam Sales Growth and Price
10.5.1 Global Carbon Ion Beam Sales Growth (2013-2018)
10.5.2 Global Carbon Ion Beam Price (2013-2018)
10.6 Alpha Particle Beam Sales Growth and Price
10.6.1 Global Alpha Particle Beam Sales Growth (2013-2018)
10.6.2 Global Alpha Particle Beam Price (2013-2018)
10.7 Beta Particle Beam Sales Growth and Price
10.7.1 Global Beta Particle Beam Sales Growth (2013-2018)
10.7.2 Global Beta Particle Beam Price (2013-2018)
11 GLOBAL HADRON THERAPY MARKET SEGMENT BY APPLICATION
11.1 Global Hadron Therapy Sales Market Share by Application (2013-2018)
11.2 Pediatric Cancer Sales Growth (2013-2018)
11.3 Bone and Soft Tissue Cancer Sales Growth (2013-2018)
11.4 Prostate Cancer Sales Growth (2013-2018)
11.5 Lung Cancer Sales Growth (2013-2018)
11.6 Liver Cancer Sales Growth (2013-2018)
11.7 Eye Cancer Sales Growth (2013-2018)
11.8 Head & Neck Cancer Sales Growth (2013-2018)
11.9 Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma) Sales Growth (2013-2018)
12 HADRON THERAPY MARKET FORECAST (2018-2023)
12.1 Global Hadron Therapy Sales, Revenue and Growth Rate (2018-2023)
12.2 Hadron Therapy Market Forecast by Regions (2018-2023)
12.2.1 North America Hadron Therapy Market Forecast (2018-2023)
12.2.2 Europe Hadron Therapy Market Forecast (2018-2023)
12.2.3 Asia-Pacific Hadron Therapy Market Forecast (2018-2023)
12.2.4 South America Hadron Therapy Market Forecast (2018-2023)
12.2.5 Middle East and Africa Hadron Therapy Market Forecast (2018-2023)
12.3 Hadron Therapy Market Forecast by Type (2018-2023)
12.3.1 Global Hadron Therapy Sales Forecast by Type (2018-2023)
12.3.2 Global Hadron Therapy Market Share Forecast by Type (2018-2023)
12.4 Hadron Therapy Market Forecast by Application (2018-2023)
12.4.1 Global Hadron Therapy Sales Forecast by Application (2018-2023)
12.4.2 Global Hadron Therapy Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure Hadron Therapy Picture
Table Product Specifications of Hadron Therapy
Figure Global Sales Market Share of Hadron Therapy by Types in 2017
Table Hadron Therapy Types for Major Manufacturers
Figure Electron Beam Picture
Figure Proton Beam Picture
Figure Neutron Beam Picture
Figure Carbon Ion Beam Picture
Figure Alpha Particle Beam Picture
Figure Beta Particle Beam Picture
Figure Hadron Therapy Sales Market Share by Applications in 2017
Figure Pediatric Cancer Picture
Figure Bone and Soft Tissue Cancer Picture
Figure Prostate Cancer Picture
Figure Lung Cancer Picture
Figure Liver Cancer Picture
Figure Eye Cancer Picture
Figure Head & Neck Cancer Picture
Figure Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma) Picture
Figure United States Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure France Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure UK Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure China Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure India Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Table Koninklijke Philips N.V. Basic Information, Manufacturing Base and Competitors
Table Koninklijke Philips N.V. Hadron Therapy Type and Applications
Table Koninklijke Philips N.V. Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Advanced Oncotherapy Basic Information, Manufacturing Base and Competitors
Table Advanced Oncotherapy Hadron Therapy Type and Applications
Table Advanced Oncotherapy Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Varian Medical Systems, Inc. Basic Information, Manufacturing Base and Competitors
Table Varian Medical Systems, Inc. Hadron Therapy Type and Applications
Table Varian Medical Systems, Inc. Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Optivus Proton Therapy, Inc. Basic Information, Manufacturing Base and Competitors
Table Optivus Proton Therapy, Inc. Hadron Therapy Type and Applications
Table Optivus Proton Therapy, Inc. Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Hitachi, Ltd. Basic Information, Manufacturing Base and Competitors
Table Hitachi, Ltd. Hadron Therapy Type and Applications
Table Hitachi, Ltd. Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mevion Medical Systems Basic Information, Manufacturing Base and Competitors
Table Mevion Medical Systems Hadron Therapy Type and Applications
Table Mevion Medical Systems Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ProTom International Basic Information, Manufacturing Base and Competitors
Table ProTom International Hadron Therapy Type and Applications
Table ProTom International Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mitsubishi Electric Corporation Basic Information, Manufacturing Base and Competitors
Table Mitsubishi Electric Corporation Hadron Therapy Type and Applications
Table Mitsubishi Electric Corporation Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sumitomo Corporation Basic Information, Manufacturing Base and Competitors
Table Sumitomo Corporation Hadron Therapy Type and Applications
Table Sumitomo Corporation Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ProNova Solutions, LLC Basic Information, Manufacturing Base and Competitors
Table ProNova Solutions, LLC Hadron Therapy Type and Applications
Table ProNova Solutions, LLC Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Hadron Therapy Sales by Manufacturer (2016-2017)
Figure Global Hadron Therapy Sales Market Share by Manufacturer in 2016
Figure Global Hadron Therapy Sales Market Share by Manufacturer in 2017
Table Global Hadron Therapy Revenue by Manufacturer (2016-2017)
Figure Global Hadron Therapy Revenue Market Share by Manufacturer in 2016
Figure Global Hadron Therapy Revenue Market Share by Manufacturer in 2017
Figure Top 3 Hadron Therapy Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Hadron Therapy Manufacturer (Revenue) Market Share in 2017
Figure Global Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Global Hadron Therapy Revenue and Growth Rate (2013-2018)
Table Global Hadron Therapy Sales by Regions (2013-2018)
Table Global Hadron Therapy Sales Market Share by Regions (2013-2018)
Table Global Hadron Therapy Revenue by Regions (2013-2018)
Figure Global Hadron Therapy Revenue Market Share by Regions in 2013
Figure Global Hadron Therapy Revenue Market Share by Regions in 2017
Figure North America Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Europe Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Hadron Therapy Sales and Growth Rate (2013-2018)
Figure South America Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Hadron Therapy Sales and Growth Rate (2013-2018)
Figure North America Hadron Therapy Revenue and Growth Rate (2013-2018)
Table North America Hadron Therapy Sales by Countries (2013-2018)
Table North America Hadron Therapy Sales Market Share by Countries (2013-2018)
Figure North America Hadron Therapy Sales Market Share by Countries in 2013
Figure North America Hadron Therapy Sales Market Share by Countries in 2017
Table North America Hadron Therapy Revenue by Countries (2013-2018)
Table North America Hadron Therapy Revenue Market Share by Countries (2013-2018)
Figure North America Hadron Therapy Revenue Market Share by Countries in 2013
Figure North America Hadron Therapy Revenue Market Share by Countries in 2017
Figure United States Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Canada Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Mexico Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Europe Hadron Therapy Revenue and Growth Rate (2013-2018)
Table Europe Hadron Therapy Sales by Countries (2013-2018)
Table Europe Hadron Therapy Sales Market Share by Countries (2013-2018)
Table Europe Hadron Therapy Revenue by Countries (2013-2018)
Figure Europe Hadron Therapy Revenue Market Share by Countries in 2016
Figure Europe Hadron Therapy Revenue Market Share by Countries in 2017
Figure Germany Hadron Therapy Sales and Growth Rate (2013-2018)
Figure UK Hadron Therapy Sales and Growth Rate (2013-2018)
Figure France Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Russia Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Italy Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Hadron Therapy Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Hadron Therapy Sales by Countries (2013-2018)
Table Asia-Pacific Hadron Therapy Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Hadron Therapy Sales Market Share by Countries 2017
Table Asia-Pacific Hadron Therapy Revenue by Countries (2013-2018)
Figure Asia-Pacific Hadron Therapy Revenue Market Share by Countries 2017
Figure China Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Japan Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Korea Hadron Therapy Sales and Growth Rate (2013-2018)
Figure India Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Southeast Asia Hadron Therapy Sales and Growth Rate (2013-2018)
Figure South America Hadron Therapy Revenue and Growth Rate (2013-2018)
Table South America Hadron Therapy Sales by Countries (2013-2018)
Table South America Hadron Therapy Sales Market Share by Countries (2013-2018)
Figure South America Hadron Therapy Sales Market Share by Countries in 2017
Table South America Hadron Therapy Revenue by Countries (2013-2018)
Table South America Hadron Therapy Revenue Market Share by Countries (2013-2018)
Figure South America Hadron Therapy Revenue Market Share by Countries in 2017
Figure Brazil Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Argentina Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Colombia Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Hadron Therapy Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Hadron Therapy Sales by Countries (2013-2018)
Table Middle East and Africa Hadron Therapy Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Hadron Therapy Sales Market Share by Countries in 2017
Table Middle East and Africa Hadron Therapy Revenue by Countries (2013-2018)
Table Middle East and Africa Hadron Therapy Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Hadron Therapy Revenue Market Share by Countries in 2013
Figure Middle East and Africa Hadron Therapy Revenue Market Share by Countries in 2017
Figure Saudi Arabia Hadron Therapy Sales and Growth Rate (2013-2018)
Figure UAE Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Egypt Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Nigeria Hadron Therapy Sales and Growth Rate (2013-2018)
Figure South Africa Hadron Therapy Sales and Growth Rate (2013-2018)
Table Global Hadron Therapy Sales by Type (2013-2018)
Table Global Hadron Therapy Sales Share by Type (2013-2018)
Table Global Hadron Therapy Revenue by Type (2013-2018)
Table Global Hadron Therapy Revenue Share by Type (2013-2018)
Figure Global Electron Beam Sales Growth (2013-2018)
Figure Global Electron Beam Price (2013-2018)
Figure Global Proton Beam Sales Growth (2013-2018)
Figure Global Proton Beam Price (2013-2018)
Figure Global Neutron Beam Sales Growth (2013-2018)
Figure Global Neutron Beam Price (2013-2018)
Figure Global Carbon Ion Beam Sales Growth (2013-2018)
Figure Global Carbon Ion Beam Price (2013-2018)
Figure Global Alpha Particle Beam Sales Growth (2013-2018)
Figure Global Alpha Particle Beam Price (2013-2018)
Figure Global Beta Particle Beam Sales Growth (2013-2018)
Figure Global Beta Particle Beam Price (2013-2018)
Table Global Hadron Therapy Sales by Application (2013-2018)
Table Global Hadron Therapy Sales Share by Application (2013-2018)
Figure Global Bone and Soft Tissue Cancer Sales Growth (2013-2018)
Figure Global Prostate Cancer Sales Growth (2013-2018)
Figure Global Lung Cancer Sales Growth (2013-2018)
Figure Global Liver Cancer Sales Growth (2013-2018)
Figure Global Eye Cancer Sales Growth (2013-2018)
Figure Global Head & Neck Cancer Sales Growth (2013-2018)
Figure Global Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma) Sales Growth (2013-2018)
Figure Global Hadron Therapy Sales, Revenue and Growth Rate (2018-2023)
Table Global Hadron Therapy Sales Forecast by Regions (2018-2023)
Table Global Hadron Therapy Market Share Forecast by Regions (2018-2023)
Figure North America Sales Hadron Therapy Market Forecast (2018-2023)
Figure Europe Sales Hadron Therapy Market Forecast (2018-2023)
Figure Asia-Pacific Sales Hadron Therapy Market Forecast (2018-2023)
Figure South America Sales Hadron Therapy Market Forecast (2018-2023)
Figure Middle East and Africa Sales Hadron Therapy Market Forecast (2018-2023)
Table Global Hadron Therapy Sales Forecast by Type (2018-2023)
Table Global Hadron Therapy Market Share Forecast by Type (2018-2023)
Table Global Hadron Therapy Sales Forecast by Application (2018-2023)
Table Global Hadron Therapy Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Figure Hadron Therapy Picture
Table Product Specifications of Hadron Therapy
Figure Global Sales Market Share of Hadron Therapy by Types in 2017
Table Hadron Therapy Types for Major Manufacturers
Figure Electron Beam Picture
Figure Proton Beam Picture
Figure Neutron Beam Picture
Figure Carbon Ion Beam Picture
Figure Alpha Particle Beam Picture
Figure Beta Particle Beam Picture
Figure Hadron Therapy Sales Market Share by Applications in 2017
Figure Pediatric Cancer Picture
Figure Bone and Soft Tissue Cancer Picture
Figure Prostate Cancer Picture
Figure Lung Cancer Picture
Figure Liver Cancer Picture
Figure Eye Cancer Picture
Figure Head & Neck Cancer Picture
Figure Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma) Picture
Figure United States Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure France Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure UK Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure China Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure India Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Hadron Therapy Revenue (Value) and Growth Rate (2013-2023)
Table Koninklijke Philips N.V. Basic Information, Manufacturing Base and Competitors
Table Koninklijke Philips N.V. Hadron Therapy Type and Applications
Table Koninklijke Philips N.V. Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Advanced Oncotherapy Basic Information, Manufacturing Base and Competitors
Table Advanced Oncotherapy Hadron Therapy Type and Applications
Table Advanced Oncotherapy Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Varian Medical Systems, Inc. Basic Information, Manufacturing Base and Competitors
Table Varian Medical Systems, Inc. Hadron Therapy Type and Applications
Table Varian Medical Systems, Inc. Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Optivus Proton Therapy, Inc. Basic Information, Manufacturing Base and Competitors
Table Optivus Proton Therapy, Inc. Hadron Therapy Type and Applications
Table Optivus Proton Therapy, Inc. Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Hitachi, Ltd. Basic Information, Manufacturing Base and Competitors
Table Hitachi, Ltd. Hadron Therapy Type and Applications
Table Hitachi, Ltd. Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mevion Medical Systems Basic Information, Manufacturing Base and Competitors
Table Mevion Medical Systems Hadron Therapy Type and Applications
Table Mevion Medical Systems Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ProTom International Basic Information, Manufacturing Base and Competitors
Table ProTom International Hadron Therapy Type and Applications
Table ProTom International Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mitsubishi Electric Corporation Basic Information, Manufacturing Base and Competitors
Table Mitsubishi Electric Corporation Hadron Therapy Type and Applications
Table Mitsubishi Electric Corporation Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sumitomo Corporation Basic Information, Manufacturing Base and Competitors
Table Sumitomo Corporation Hadron Therapy Type and Applications
Table Sumitomo Corporation Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ProNova Solutions, LLC Basic Information, Manufacturing Base and Competitors
Table ProNova Solutions, LLC Hadron Therapy Type and Applications
Table ProNova Solutions, LLC Hadron Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Hadron Therapy Sales by Manufacturer (2016-2017)
Figure Global Hadron Therapy Sales Market Share by Manufacturer in 2016
Figure Global Hadron Therapy Sales Market Share by Manufacturer in 2017
Table Global Hadron Therapy Revenue by Manufacturer (2016-2017)
Figure Global Hadron Therapy Revenue Market Share by Manufacturer in 2016
Figure Global Hadron Therapy Revenue Market Share by Manufacturer in 2017
Figure Top 3 Hadron Therapy Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Hadron Therapy Manufacturer (Revenue) Market Share in 2017
Figure Global Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Global Hadron Therapy Revenue and Growth Rate (2013-2018)
Table Global Hadron Therapy Sales by Regions (2013-2018)
Table Global Hadron Therapy Sales Market Share by Regions (2013-2018)
Table Global Hadron Therapy Revenue by Regions (2013-2018)
Figure Global Hadron Therapy Revenue Market Share by Regions in 2013
Figure Global Hadron Therapy Revenue Market Share by Regions in 2017
Figure North America Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Europe Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Hadron Therapy Sales and Growth Rate (2013-2018)
Figure South America Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Hadron Therapy Sales and Growth Rate (2013-2018)
Figure North America Hadron Therapy Revenue and Growth Rate (2013-2018)
Table North America Hadron Therapy Sales by Countries (2013-2018)
Table North America Hadron Therapy Sales Market Share by Countries (2013-2018)
Figure North America Hadron Therapy Sales Market Share by Countries in 2013
Figure North America Hadron Therapy Sales Market Share by Countries in 2017
Table North America Hadron Therapy Revenue by Countries (2013-2018)
Table North America Hadron Therapy Revenue Market Share by Countries (2013-2018)
Figure North America Hadron Therapy Revenue Market Share by Countries in 2013
Figure North America Hadron Therapy Revenue Market Share by Countries in 2017
Figure United States Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Canada Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Mexico Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Europe Hadron Therapy Revenue and Growth Rate (2013-2018)
Table Europe Hadron Therapy Sales by Countries (2013-2018)
Table Europe Hadron Therapy Sales Market Share by Countries (2013-2018)
Table Europe Hadron Therapy Revenue by Countries (2013-2018)
Figure Europe Hadron Therapy Revenue Market Share by Countries in 2016
Figure Europe Hadron Therapy Revenue Market Share by Countries in 2017
Figure Germany Hadron Therapy Sales and Growth Rate (2013-2018)
Figure UK Hadron Therapy Sales and Growth Rate (2013-2018)
Figure France Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Russia Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Italy Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Hadron Therapy Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Hadron Therapy Sales by Countries (2013-2018)
Table Asia-Pacific Hadron Therapy Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Hadron Therapy Sales Market Share by Countries 2017
Table Asia-Pacific Hadron Therapy Revenue by Countries (2013-2018)
Figure Asia-Pacific Hadron Therapy Revenue Market Share by Countries 2017
Figure China Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Japan Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Korea Hadron Therapy Sales and Growth Rate (2013-2018)
Figure India Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Southeast Asia Hadron Therapy Sales and Growth Rate (2013-2018)
Figure South America Hadron Therapy Revenue and Growth Rate (2013-2018)
Table South America Hadron Therapy Sales by Countries (2013-2018)
Table South America Hadron Therapy Sales Market Share by Countries (2013-2018)
Figure South America Hadron Therapy Sales Market Share by Countries in 2017
Table South America Hadron Therapy Revenue by Countries (2013-2018)
Table South America Hadron Therapy Revenue Market Share by Countries (2013-2018)
Figure South America Hadron Therapy Revenue Market Share by Countries in 2017
Figure Brazil Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Argentina Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Colombia Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Hadron Therapy Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Hadron Therapy Sales by Countries (2013-2018)
Table Middle East and Africa Hadron Therapy Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Hadron Therapy Sales Market Share by Countries in 2017
Table Middle East and Africa Hadron Therapy Revenue by Countries (2013-2018)
Table Middle East and Africa Hadron Therapy Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Hadron Therapy Revenue Market Share by Countries in 2013
Figure Middle East and Africa Hadron Therapy Revenue Market Share by Countries in 2017
Figure Saudi Arabia Hadron Therapy Sales and Growth Rate (2013-2018)
Figure UAE Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Egypt Hadron Therapy Sales and Growth Rate (2013-2018)
Figure Nigeria Hadron Therapy Sales and Growth Rate (2013-2018)
Figure South Africa Hadron Therapy Sales and Growth Rate (2013-2018)
Table Global Hadron Therapy Sales by Type (2013-2018)
Table Global Hadron Therapy Sales Share by Type (2013-2018)
Table Global Hadron Therapy Revenue by Type (2013-2018)
Table Global Hadron Therapy Revenue Share by Type (2013-2018)
Figure Global Electron Beam Sales Growth (2013-2018)
Figure Global Electron Beam Price (2013-2018)
Figure Global Proton Beam Sales Growth (2013-2018)
Figure Global Proton Beam Price (2013-2018)
Figure Global Neutron Beam Sales Growth (2013-2018)
Figure Global Neutron Beam Price (2013-2018)
Figure Global Carbon Ion Beam Sales Growth (2013-2018)
Figure Global Carbon Ion Beam Price (2013-2018)
Figure Global Alpha Particle Beam Sales Growth (2013-2018)
Figure Global Alpha Particle Beam Price (2013-2018)
Figure Global Beta Particle Beam Sales Growth (2013-2018)
Figure Global Beta Particle Beam Price (2013-2018)
Table Global Hadron Therapy Sales by Application (2013-2018)
Table Global Hadron Therapy Sales Share by Application (2013-2018)
Figure Global Bone and Soft Tissue Cancer Sales Growth (2013-2018)
Figure Global Prostate Cancer Sales Growth (2013-2018)
Figure Global Lung Cancer Sales Growth (2013-2018)
Figure Global Liver Cancer Sales Growth (2013-2018)
Figure Global Eye Cancer Sales Growth (2013-2018)
Figure Global Head & Neck Cancer Sales Growth (2013-2018)
Figure Global Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma) Sales Growth (2013-2018)
Figure Global Hadron Therapy Sales, Revenue and Growth Rate (2018-2023)
Table Global Hadron Therapy Sales Forecast by Regions (2018-2023)
Table Global Hadron Therapy Market Share Forecast by Regions (2018-2023)
Figure North America Sales Hadron Therapy Market Forecast (2018-2023)
Figure Europe Sales Hadron Therapy Market Forecast (2018-2023)
Figure Asia-Pacific Sales Hadron Therapy Market Forecast (2018-2023)
Figure South America Sales Hadron Therapy Market Forecast (2018-2023)
Figure Middle East and Africa Sales Hadron Therapy Market Forecast (2018-2023)
Table Global Hadron Therapy Sales Forecast by Type (2018-2023)
Table Global Hadron Therapy Market Share Forecast by Type (2018-2023)
Table Global Hadron Therapy Sales Forecast by Application (2018-2023)
Table Global Hadron Therapy Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
